ESR2 and prostate cancer: Although epigenetic regulation of ERβ in prostate cancer has been reported (Zhu et al. 2004), knowledge of what cis-acting factors directly interact with the ERβ promoter is very limited; AP-2 was recently found to be a promising transcription factor that regulates ERβ gene expression (Zhang et al., in press).